Gynecomastia Procedures Market Size, Share, Opportunities, And Trends By Age Group (18-40, Above 40), By Procedure (Liposuction, Excision), By End-Use (Hospitals, Cosmetic Surgery Centers), And By Geography - Forecasts From 2023 To 2028

The gynecomastia procedures market was valued at US$629.42 million in 2021.

It is anticipated that the gynecomastia procedures market will expand steadily.  Gynecomastia is an abnormal growth or swelling of the breast tissue that affects men and is mostly brought on by an estrogen and testosterone imbalance. Boys and men of all ages can develop it, although middle-aged to older males and those in their early to mid-adolescence are the most likely to do so. Other potential risk factors for gynecomastia include genetic makeup, the use of certain pharmaceuticals (such as anti-androgens, anti-depressants, and so forth), excessive herbal product usage, and obesity. Gynecomastia, while mostly an aesthetic issue and not a major medical ailment, can make people uncomfortable and cause social issues, especially in boys and young men.

Key growth drivers

The usage of drugs like anabolic steroids and antidepressants for hormonal imbalances and obesity is the main driver of gynecomastia procedures market growth. In addition, sedentary behaviours and poor food choices are contributing factors to the rise in gynecomastia prevalence. The introduction of less invasive treatments like liposuction and glandular tissue excision, as well as improvements in treatment alternatives, have all contributed to the gynecomastia procedures market growth. Since liposuction has a success rate of 85% to 95%, there is a significant demand for this surgery as a therapeutic option.

Increasing cases of gynecomastia

Gynecomastia incidences have increased dramatically in recent years. It is therefore commonly acknowledged to be a rather common disorder. Gynecomastia affects 50–60% of teenage boys during puberty, according to the National Library of Medicine, albeit the majority of instances are minor and go away on their own without any kind of therapy. Gynecomastia prevalence also varies based on the community being investigated. With aging, the prevalence tends to rise, with older males experiencing it at greater rates.

The dominance of the above 40 age group in the gynecomastia procedures market

The over-40 age group dominates the gynecomastia procedures market due to things like hormonal changes, the long-term consequences of risk factors, the usage of medications, the prevalence of health concerns in older people, and higher financial capacity. Men's hormones alter naturally as they age, increasing their chance of developing gynecomastia. Older people are more prone to gynecomastia due to the fall in testosterone levels and rise in body fat, which promotes the growth of breast tissue. On the other hand, the 18 to 40 age group is anticipated to have profitable development throughout the projection period. When hormonal changes are at their most intense throughout puberty, gynecomastia frequently develops.

Advanced minimally invasive procedure approaches

The range of available treatments for gynecomastia has been broadened due to modern minimally invasive procedural techniques such as glandular tissue removal and liposuction. These developments have raised patient satisfaction and results, which is further fueling the gynecomastia procedures market growth. Additionally, because this therapy offers less intrusive procedures, lower scarring, quicker recovery periods, and greater cosmetic results, minimally invasive treatments have grown in favor of treating gynecomastia.

Power-assisted liposuction (PAL) and ultrasound-assisted liposuction (UAL) are two examples of advanced liposuction treatments that offer higher accuracy and better outcomes. Smartlipo and VASERlipo, two laser-assisted liposuction procedures, use laser or ultrasound energy to liquefy fat cells before removal. This method can aid in skin tightening and enhance the overall shape.

Rising focus on physical appearance

The rising link between self-esteem and beauty will also fuel gynecomastia procedures market expansion. A 2022 Journal of Education and Health Promotion paper found that unhealthy weight in young adults was inversely correlated with self-esteem. The American Academy of Dermatology Association also reports that elderly people undergoing cosmetic operations did not have any severe negative effects. Additionally, due to a better lifestyle, older patients had better procedural outcomes from body-contouring treatments like gynecomastia than the younger age group.

Excision procedure is propelling

Surgical excision is more efficient than liposuction when gynecomastia involves the expansion of glandular tissue rather than merely extra fat. Also helping to boost excision surgery's appeal are improvements in surgical methods for removing glandular tissue. With the advancement of surgical techniques, it is now possible to remove glandular tissue more successfully and with little scarring. These developments have boosted both patients' and surgeons' trust in excision surgery as a therapy option which is further fueling the gynecomastia procedures market share.

Increasing cosmetic surgery centers

Cosmetic surgery centers are anticipated to be the biggest gynecomastia procedures market share due to their expertise in a range of aesthetic operations, such as those about body contouring and breast surgery. Gynecomastia treatments are frequently carried out by surgeons in these facilities who have a great deal of experience and competence in doing so, resulting in excellent results and patient satisfaction. Additionally, several long-term patient trial data attest to the security of patients in these facilities. According to the American Society of Plastic Surgeons, cosmetic treatments carried done outside of a hospital have a complication risk of less than 1%.

In North America, substantial growth is anticipated in the market for gynecomastia procedures market.

Advanced healthcare infrastructure, a strict regulatory framework, a focus on patient safety and treatment quality, and the presence of important companies are the drivers that propel North American gynecomastia procedures market share. Additionally, people are more likely to pursue gynecomastia therapies due to the increased accessibility to healthcare facilities and the proportionate increase in disposable money. With several specialized clinics, hospitals, and healthcare organizations offering a wide range of treatment alternatives, the North American industry is extremely competitive.

Market Key Developments

• In March 2023, In Gujarat, Cadila Pharma announced plans to expand their current plant with a large expenditure of Rs 1,000 crore.
• In October 2022, Clarus Therapeutics Holdings, Inc. (OTC: CRXTQ) and its wholly-owned subsidiary Clarus Therapeutics, Inc. (collectively, "Clarus") sold Tolmar Pharmaceuticals, Inc., a fully integrated pharmaceutical company, all of the rights to JATENZO®.

Segmentation:

• By Age Group
  • 18-40
  • Above 40
• By Procedure
  • Liposuction
  • Excision
• By End-Use
  • Hospitals
  • Cosmetic Surgery Centers
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Others